Microbot Medical Business Model Canvas

Microbot Medical Inc. Medical Devices / Surgical Robotics
Free preview

Key Partnerships

  • Medical device component suppliers
  • Contract manufacturers (CMOs — LIBERTY production)
  • Clinical trial sites & hospital partners
  • FDA regulatory consultants & advisors
  • Strategic distribution partners (future commercialization)
  • Interventional cardiology & radiology KOLs
  • Technology licensors (micro-robotics, catheter technology)

Key Activities

  • LIBERTY robotic platform engineering & iteration
  • Preclinical testing & benchtop validation
  • Clinical trials & regulatory submissions (FDA 510(k)/De Novo)
  • Manufacturing process development & scale-up
  • Physician feedback integration & product refinement
  • Intellectual property development & patent filings
  • Capital raising & investor relations

Key Resources

  • LIBERTY endovascular robotic system IP & patents
  • Engineering & clinical development team
  • Regulatory submission history & FDA interactions
  • Prototype & pilot manufacturing capabilities
  • Clinical advisory board (interventional specialists)
  • Investor relationships & funding
  • Micro-robotics technology expertise
Free preview

Value Propositions

  • LIBERTY robotic platform (reduced radiation exposure for surgeons)
  • Single-use disposable design (no reprocessing — infection control)
  • Micro-robotic precision for endovascular catheter navigation
  • Remote-controlled operation (surgeon distance from radiation source)
  • Compact, cost-effective robotic system (vs. large surgical robots)
  • Potential for improved procedural outcomes through robotic precision
  • Applicable across endovascular & neurovascular procedures

Customer Relationships

  • Clinical advisory board engagement (physician input into design)
  • Key opinion leader (KOL) partnerships
  • Physician training & simulation programs (future)
  • Medical conference demonstrations & presentations
  • Transparent investor & stakeholder communications
  • Early adopter programs (pilot hospital placements)
  • Post-market clinical support (future)

Channels

  • Direct sales to hospitals & cath labs (future)
  • Medical device distributor partnerships (future commercialization)
  • Medical conferences & trade shows (TCT, VIVA, LINC)
  • Scientific publications & clinical data presentations
  • FDA regulatory pathway (510(k), De Novo)
  • microbotmedical.com corporate communications
  • Investor conferences & healthcare events
Free preview

Customer Segments

  • Interventional cardiologists (endovascular procedures)
  • Interventional radiologists (vascular access procedures)
  • Neurovascular surgeons (stroke intervention)
  • Hospital catheterization labs (capital equipment buyers)
  • Ambulatory surgical centers (outpatient procedures)
  • Medical device distributors (channel partners)
  • Hospital purchasing committees & value analysis teams

Cost Structure

  • R&D expenses (largest — engineering, prototyping, testing)
  • Clinical trial costs (site fees, patient enrollment, monitoring)
  • Regulatory submission & compliance costs
  • Employee compensation (engineering, clinical, regulatory team)
  • Manufacturing development & pilot production
  • Intellectual property & patent prosecution
  • General & administrative (public company costs — NASDAQ: MBOT)

Revenue Streams

  • Future LIBERTY system placement/sales (capital equipment)
  • Per-procedure disposable cassette revenue (recurring — razor/blade model)
  • Service & maintenance contracts (system upkeep)
  • Potential licensing to larger medtech companies
  • Technology licensing fees
  • Training & education program fees
  • Strategic partnership milestone payments

Microbot Medical Business Model Canvas: Complete BMC Analysis

The Microbot Medical Business Model Canvas reveals how this pre-revenue medical robotics company is developing the LIBERTY robotic system — a single-use, disposable micro-robotic platform for endovascular surgical procedures. Based in Hingham, Massachusetts, this BMC framework analysis covers Microbot Medical's nine building blocks.

Value Propositions in Microbot Medical's BMC

Microbot Medical's Value Propositions include the LIBERTY robotic platform (reducing surgeon radiation exposure during endovascular procedures), single-use disposable design (eliminating reprocessing costs), micro-robotic precision for minimally invasive procedures, and remote-controlled catheter navigation. This surgical robotics innovation complements the Siemens Business Model Canvas medical imaging and the Philips Business Model Canvas healthcare technology portfolios.

Customer Segments Analysis

Microbot Medical's Customer Segments include interventional cardiologists and radiologists, neurovascular surgeons, hospital catheterization labs, ambulatory surgical centers, and medical device distributors. The Lantheus Business Model Canvas targets similar hospital-based imaging departments.

Key Partners and Key Resources

The Key Partners include medical device component suppliers, contract manufacturers, clinical trial sites (hospitals), FDA regulatory consultants, and strategic distribution partners. Key Resources encompass the LIBERTY robotic platform IP and patents, engineering and clinical team, regulatory submissions, and prototype manufacturing capabilities.

Revenue Streams and Cost Structure

Microbot Medical's Revenue Streams (future — pre-revenue) include LIBERTY system sales/placement, per-procedure disposable cassette revenue (recurring), service contracts, and potential licensing to larger medtech companies. The Cost Structure includes R&D (largest), clinical trial expenses, regulatory costs, and G&A. Compare this med-device approach to the Philips Business Model Canvas and Siemens Business Model Canvas medical devices.

Channels and Customer Relationships

Microbot Medical's Channels include direct sales to hospitals (future), medical device distributor partnerships, medical conferences (TCT, VIVA), and regulatory submissions. Customer Relationships leverage clinical advisory boards, physician training programs, and key opinion leader engagement.

Key Activities in the BMC Framework

Microbot Medical's Key Activities include LIBERTY platform engineering and iteration, preclinical and clinical testing, FDA regulatory pathway navigation, manufacturing development, and physician feedback integration. These medical robotics activities advance alongside Allarity Therapeutics and Intellia Therapeutics in transforming healthcare.

Comparing Medical Device & Healthcare Business Model Canvases

Study related BMC analyses: the Philips BMC for health tech, Siemens BMC for medical imaging, J&J BMC for medical devices, Lantheus BMC for radiopharmaceuticals, and Allarity Therapeutics BMC for precision oncology. Also explore: Intellia Therapeutics BMC for gene editing and Bayer BMC for life sciences.

Build your own canvas like Microbot Medical Inc.'s

Use Microbot Medical Inc.'s model as a blueprint. Create, customize and export your own Business Model Canvas in minutes.

Start building — free
Full access for 7 days · No charge · Cancel anytime 30-day money-back guarantee

Frequently asked questions about Microbot Medical Inc.

How does Microbot Medical Inc. make money?

Microbot Medical Inc. makes money primarily through Future LIBERTY system placement/sales (capital equipment), Per-procedure disposable cassette revenue (recurring — razor/blade model), Service & maintenance contracts (system upkeep), Potential licensing to larger medtech companies, Technology licensing fees and Training & education program fees. These revenue streams are the foundation of Microbot Medical Inc.'s business model and show how the company monetizes the value it creates for its customers.

What is Microbot Medical Inc.'s business model?

Microbot Medical Inc.'s business model is built on delivering LIBERTY robotic platform (reduced radiation exposure for surgeons), Single-use disposable design (no reprocessing — infection control), Micro-robotic precision for endovascular catheter navigation, Remote-controlled operation (surgeon distance from radiation source), Compact, cost-effective robotic system (vs. large surgical robots) and Potential for improved procedural outcomes through robotic precision. It targets Interventional cardiologists (endovascular procedures), Interventional radiologists (vascular access procedures), Neurovascular surgeons (stroke intervention), Hospital catheterization labs (capital equipment buyers), Ambulatory surgical centers (outpatient procedures) and Medical device distributors (channel partners) and generates revenue from Future LIBERTY system placement/sales (capital equipment), Per-procedure disposable cassette revenue (recurring — razor/blade model), Service & maintenance contracts (system upkeep), Potential licensing to larger medtech companies, Technology licensing fees and Training & education program fees, mapped across the nine building blocks of the Business Model Canvas.

Who are Microbot Medical Inc.'s target customers?

Microbot Medical Inc. primarily serves Interventional cardiologists (endovascular procedures), Interventional radiologists (vascular access procedures), Neurovascular surgeons (stroke intervention), Hospital catheterization labs (capital equipment buyers), Ambulatory surgical centers (outpatient procedures) and Medical device distributors (channel partners). Understanding these customer segments is key to how Microbot Medical Inc. designs its products, pricing and go-to-market strategy.

What is Microbot Medical Inc.'s value proposition?

Microbot Medical Inc.'s core value propositions are LIBERTY robotic platform (reduced radiation exposure for surgeons), Single-use disposable design (no reprocessing — infection control), Micro-robotic precision for endovascular catheter navigation, Remote-controlled operation (surgeon distance from radiation source), Compact, cost-effective robotic system (vs. large surgical robots) and Potential for improved procedural outcomes through robotic precision. These are the main reasons customers choose Microbot Medical Inc. over the alternatives.

Who are Microbot Medical Inc.'s key partners?

Microbot Medical Inc. works with key partners such as Medical device component suppliers, Contract manufacturers (CMOs — LIBERTY production), Clinical trial sites & hospital partners, FDA regulatory consultants & advisors, Strategic distribution partners (future commercialization) and Interventional cardiology & radiology KOLs. These partnerships help Microbot Medical Inc. reduce risk, access resources and scale its business model.

What are Microbot Medical Inc.'s main costs?

Microbot Medical Inc.'s cost structure is driven mainly by R&D expenses (largest — engineering, prototyping, testing), Clinical trial costs (site fees, patient enrollment, monitoring), Regulatory submission & compliance costs, Employee compensation (engineering, clinical, regulatory team), Manufacturing development & pilot production and Intellectual property & patent prosecution. Managing these costs efficiently is central to Microbot Medical Inc.'s profitability and long-term sustainability.